Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC1R | Q01726 | 7/20 | 0.40 |
| ▸ | MC4R | P32245 | 7/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1311385 | 0.80 | MC1R (0.49) | MC1RMC4RAPP | |
| Hydrochloric Acid SCHEMBL2148837 | 0.79 | MC1R (0.45) | MC1RMC4RAPP | |
| SCHEMBL2161645 | 0.74 | MC1R (0.43) | MC1RMC4RAPP | |
| SCHEMBL1310202 | 0.74 | MC1R (0.47) | MC1RMC4R | |
| SCHEMBL1310191 | 0.72 | MC1R (0.49) | MC1RMC4R | |
| SCHEMBL1309979 | 0.72 | MC1R (0.50) | MC1RMC4RAPP | |
| SCHEMBL1309669 | 0.72 | MC1R (0.40) | MC1RMC4RAPP | |
| SCHEMBL2148734 | 0.71 | MC1R (0.37) | MC1RMC4R | |
| Trifluoroacetic Acid SCHEMBL1310217 | 0.70 | MC1R (0.57) | MC1RMC4R | |
| Trifluoroacetic Acid SCHEMBL1311384 | 0.70 | MC1R (0.58) | MC1RMC4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2342194-A1 | OXOAZETIDINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS | Galderma Research & Development (FR) | 2011-07-13 | — | — | EP | disclosed |
| WO-2010052253-A1 | OXOAZETIDINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2010-05-14 | — | — | WO | disclosed |